San Diego, Calif – April 14, 2020 — Crown Bioscience has announced the appointment of Jean-Pierre Wery, PhD as executive chairman of the board effective immediately. Dr. Wery will also serve as chief technology officer (CTO) for JSR Life Sciences, LLC.
JSR acquired CrownBio in 2018 to expand their life science portfolio to serve the preclinical market. In this new role, Dr. Wery will lead the JSR Life Sciences companies’ collaborative efforts to identify strategic synergies and develop innovative technologies, platforms and tools for the drug and biomarker research communities. This leadership change ensures enhanced collaboration between CrownBio and the JSR Life Sciences family of companies to expand their already significant life sciences footprint.
CrownBio is also pleased to announce the appointment of Armin Spura, PhD to succeed Dr. Wery as chief executive officer, effective from April 1, 2020. As CEO, Dr. Spura will drive the global corporate strategy for CrownBio, further strengthening the company’s position at the forefront of preclinical research services across oncology, metabolic disease and inflammation.
“I have embraced and enjoyed the varied challenges inherent in growing CrownBio into a world-leading, global preclinical CRO,” said Dr. Wery. “It is now the right time to hand over the reins to Armin to lead the company into the next period of innovation and growth”.
CrownBio is a leading contract research organization (CRO) in both the drug discovery and biomarker discovery arenas with a range of innovative product portfolios available across sites in Asia, the US and Europe. CrownBio currently employs more than 700 people.
“I am delighted to join CrownBio and to continue the company’s pioneering approach to developing new solutions for our clients,” said Dr. Spura. “I believe CrownBio is uniquely innovative within the preclinical CRO arena, and that innovation will remain a core to our identity, growth and market leadership position.”
Contact details
-
- Louise Stenson
-
Crown Bioscience Company Inquiries
Communications Manager - louise.stenson@crownbio.com
Related topics
Related news
Crown Bioscience Wins 2024 Fierce CRO Award for Excellence in Client Service and Partnership
Crown Bioscience wins 2024 Fierce CRO Award for excellence in client service, underscoring its commitment to innovative drug development partnerships.
Crown Bioscience Wins BioTech Breakthrough Award for Drug Development Innovation
Crown Bioscience's OrganoidXplore receives BioTech Award, revolutionizing oncology with advanced preclinical screening.
Prostate Cancer Breakthrough: Crown Bioscience Collaborates in €1.75M Eurostars Funded Project for Novel Liquid Biops...
Crown Bioscience, part of JSR Life Sciences, joins a €1.75M Eurostars project to develop a novel liquid biopsy for prostate cancer, enhancing treatment.
Crown Bioscience Expands Singapore Facility with Advanced Oncology Models and Imaging Capabilities
Crown Bioscience enhances its global presence with the expansion of its Singapore facility, featuring cutting-edge oncology models and imaging capabilities.
Crown Bioscience Partners with CTI to Support Consulting Services in Oncology Drug Development
Crown Bioscience announces a strategic partnership with Clinical Trial & Consulting Services (CTI), a renowned global full-spectrum research service provider, to bolster oncology-focused consulting...